KM Research Hub

LITERATURE

原始候选快照

v3 复核前的候选池,完整保留,仅供查看,不会自动重新处理。 共 7004 篇。

导出 CSV
论文标识日期入排置信度入排依据KM 状态
Biochemical Relapse-Free Survival in Postprostatectomy Patients Receiving 18F-Fluciclovine-Guided Prostate Bed-Only Radiation: Post Hoc Analysis of a Prospective Randomized Trial.Pract Radiat OncolPMID 39032598PMC1244780420240.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Early health technology assessment of gene silencing therapies for lowering lipoprotein(a) in the secondary prevention of coronary heart disease.J Clin LipidolPMID 39322524无 PMCID20240.98未发现恶性肿瘤人群证据。待处理
Safety, immunogenicity and immune-persistence of a lyophilized human rabies vaccine (Vero cells) under Zagreb and Essen regimens: a randomized, open-label, controlled phase III clinical trial in healthy participants aged 10-60 years in China.Front ImmunolPMID 39575262PMC1157897120240.98未发现恶性肿瘤人群证据。待处理
Immunogenicity of dupilumab in adult and pediatric patients with atopic dermatitis.Front ImmunolPMID 39588375PMC1158671720240.98未发现恶性肿瘤人群证据。待处理
Changes to inflammatory markers during 5 years of viral suppression and during viral blips in people with HIV initiating different integrase inhibitor based regimens.Front ImmunolPMID 39600696PMC1159012020240.95The record is a Phase III randomized trial in humans with a drug intervention (antiretroviral therapy), but it is non-oncology (focused on HIV infections and inflammation markers, not malignant neoplasms). The primary endpoint is changes in inflammatory biomarkers, not a time-to-event efficacy outcome like OS or PFS.待处理
Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate versus Dual Therapies for Patients with COPD and Phenotypic Features of Asthma: A Pooled Post Hoc Analysis of KRONOS and ETHOS.Int J Chron Obstruct Pulmon DisPMID 39691156PMC1164957720240.98未发现恶性肿瘤人群证据。待处理
Antidrug antibodies to adalimumab do not associate with immunologically related adverse events.Front ImmunolPMID 40084239PMC1190441220240.98未发现恶性肿瘤人群证据。待处理
Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered as a booster to adults aged ≥59 years: A phase III randomized study.Hum Vaccin ImmunotherPMID 36632042PMC99806252023-Dec-310.98未发现恶性肿瘤人群证据。待处理
Immunogenicity and safety of Biological E's CORBEVAX™ vaccine compared to COVISHIELD™ (ChAdOx1 nCoV-19) vaccine studied in a phase-3, single blind, multicentre, randomized clinical trial.Hum Vaccin ImmunotherPMID 37113012PMC102947212023-Dec-310.98未发现恶性肿瘤人群证据。待处理
A randomized, observer-blind, controlled phase III clinical trial assessing safety and immunological non-inferiority of Vi-diphtheria toxoid versus Vi-tetanus toxoid typhoid conjugate vaccine in healthy volunteers in eastern Nepal.Hum Vaccin ImmunotherPMID 37128723PMC101423052023-Dec-310.98未发现恶性肿瘤人群证据。待处理
Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10-50 years old: Randomized, blinded, parallel controlled phase III clinical study.Hum Vaccin ImmunotherPMID 37249318PMC102947202023-Dec-310.98未发现恶性肿瘤人群证据。待处理
Phase III study of bilayer sustained-release tramadol tablets in patients with cancer pain: a double-blind parallel-group, non-inferiority study with immediate-release tramadol capsules as an active comparator.Support Care CancerPMID 38157081PMC107568902023-Dec-290.95The study is a randomized, Phase III oncology trial with a drug intervention and original results, but it does not have a primary or key secondary time-to-event efficacy endpoint as required for inclusion.待处理
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.N Engl J MedPMID 37921461无 PMCID2023-Dec-280.98未发现恶性肿瘤人群证据。待处理
Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia.N Engl J MedPMID 37952133PMC108370042023-Dec-280.98未发现恶性肿瘤人群证据。待处理
Efficacy and safety of nemolizumab in paediatric patients aged 6-12 years with atopic dermatitis with moderate-to-severe pruritus: results from a phase III, randomized, double-blind, placebo-controlled, multicentre study.Br J DermatolPMID 37522351无 PMCID2023-Dec-200.98未发现恶性肿瘤人群证据。待处理
Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization.J Clin OncolPMID 37722087无 PMCID2023-Dec-200.96明确的 Phase III/IIIb/II-III 随机肿瘤药物试验,且报告 time-to-event 结局。待处理
Biosimilar SB15 versus reference aflibercept in neovascular age-related macular degeneration: 1-year and switching results of a phase 3 clinical trial.BMJ Open OphthalmolPMID 38114333PMC107490852023-Dec-190.98未发现恶性肿瘤人群证据。待处理
Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial.LancetPMID 37931632无 PMCID2023-Dec-160.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Ubrogepant for the treatment of migraine attacks during the prodrome: a phase 3, multicentre, randomised, double-blind, placebo-controlled, crossover trial in the USA.LancetPMID 37979595无 PMCID2023-Dec-160.98未发现恶性肿瘤人群证据。待处理
Efbemalenograstim alfa, an Fc fusion protein, long-acting granulocyte-colony stimulating factor for reducing the risk of febrile neutropenia following chemotherapy: results of a phase III trial.Support Care CancerPMID 38103088PMC107253752023-Dec-160.95The study meets criteria for oncology, human, randomized, Phase III, drug intervention, and original result. However, it fails the time-to-event criterion because the primary endpoint is duration of severe neutropenia (a continuous/mean difference endpoint), not a time-to-event efficacy endpoint (e.g., OS, PFS) requiring Kaplan-Meier analysis.待处理
Early Video-assisted Thoracoscopic Surgery or Intrapleural Enzyme Therapy in Pleural Infection: A Feasibility Randomized Controlled Trial. The Third Multicenter Intrapleural Sepsis Trial-MIST-3.Am J Respir Crit Care MedPMID 37820359PMC107654022023-Dec-150.98未发现恶性肿瘤人群证据。待处理
Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial.Clin Cancer ResPMID 37843857无 PMCID2023-Dec-150.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Phase III randomized clinical studies to evaluate the immunogenicity, lot-to-lot consistency, and safety of ROTAVAC® liquid formulations (ROTAVAC 5C & 5D) and non-inferiority comparisons with licensed ROTAVAC® (frozen formulation) in healthy infants.Hum Vaccin ImmunotherPMID 37968237PMC107603722023-Dec-150.98未发现恶性肿瘤人群证据。待处理
Efficacy and safety of eptinezumab in patients with chronic migraine and medication-overuse headache: a randomized, double-blind, placebo-controlled study.BMC NeurolPMID 38102535PMC107227042023-Dec-150.98未发现恶性肿瘤人群证据。待处理
Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma.N Engl J MedPMID 37870955PMC111889862023-Dec-140.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults.N Engl J MedPMID 38091530无 PMCID2023-Dec-140.98未发现恶性肿瘤人群证据。待处理
NeuroEPO plus (NeuralCIM®) in mild-to-moderate Alzheimer's clinical syndrome: the ATHENEA randomized clinical trial.Alzheimers Res TherPMID 38093366PMC107169562023-Dec-130.98未发现恶性肿瘤人群证据。待处理
A Randomized, Double-Blind, Active Control, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Liztox® versus Botox® in Post-Stroke Upper Limb Spasticity.Toxins (Basel)PMID 38133201PMC107482612023-Dec-120.98未发现恶性肿瘤人群证据。待处理
A Randomized Placebo-Controlled Trial of the Anti-Nerve Growth Factor Antibody Tanezumab in Subjects With Cancer Pain Due to Bone Metastasis.OncologistPMID 37343145PMC107127172023-Dec-110.95The study is a Phase III randomized controlled trial in oncology patients with a drug intervention (tanezumab) and presents original results. However, the primary efficacy endpoint is change in pain score (continuous outcome) at week 8, not a time-to-event endpoint such as OS, PFS, DFS, EFS, RFS, TTP, or any Kaplan-Meier or hazard ratio analysis. Therefore, it does not meet the time-to-event criterion for inclusion in the KM digitization cohort.待处理
Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer.J Clin OncolPMID 37669480无 PMCID2023-Dec-100.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer.J Clin OncolPMID 37695982PMC107131402023-Dec-100.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial.LancetPMID 37871604无 PMCID2023-Dec-091.00命中用户提供的消化道肿瘤阳性参考集。待处理
Efficacy and safety of CKD-495 in acute and chronic gastritis: A Phase III superiority clinical trial.Medicine (Baltimore)PMID 38065906PMC107131942023-Dec-080.98未发现恶性肿瘤人群证据。待处理
Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes.N Engl J MedPMID 37861217无 PMCID2023-Dec-070.98未发现恶性肿瘤人群证据。待处理
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C.N Engl J MedPMID 37870968无 PMCID2023-Dec-071.00命中用户提供的消化道肿瘤阳性参考集。待处理
A phase 3 study evaluating the lot consistency, immunogenicity, safety, and tolerability of a Clostridioides difficile vaccine in healthy adults 65 to 85 years of age.VaccinePMID 37977942无 PMCID2023-Dec-070.98未发现恶性肿瘤人群证据。待处理
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.N Engl J MedPMID 38055253无 PMCID2023-Dec-070.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer: The ORIENT-16 Randomized Clinical Trial.JAMAPMID 38051328PMC106986182023-Dec-051.00命中用户提供的消化道肿瘤阳性参考集。待处理
A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial.TrialsPMID 38053196PMC106966672023-Dec-050.98未发现恶性肿瘤人群证据。待处理
AGO-OVAR 28/ENGOT-ov57. Niraparib alone versus niraparib in combination with bevacizumab in patients with carboplatin-taxane-based chemotherapy in advanced ovarian cancer: a multicenter randomized phase III trial.Int J Gynecol CancerPMID 37935524无 PMCID2023-Dec-040.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.LancetPMID 37931634无 PMCID2023-Dec-020.98未发现恶性肿瘤人群证据。待处理
Perinatal Outcomes Associated With Management of Stage 1 Hypertension.Obstet GynecolPMID 37769314PMC108407062023-Dec-010.98未发现恶性肿瘤人群证据。待处理
Cost-effectiveness analysis of an orphan drug tebentafusp in patients with metastatic uveal melanoma and a call for value-based pricing.Melanoma ResPMID 37650713无 PMCID2023-Dec-010.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Five-Year Overall Survival Analysis of the JIPANG Study: Pemetrexed or Vinorelbine Plus Cisplatin for Resected Stage II-IIIA Nonsquamous Non-Small-Cell Lung Cancer.J Clin OncolPMID 37656928无 PMCID2023-Dec-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Neoadjuvant docetaxel, oxaliplatin plus capecitabine versus oxaliplatin plus capecitabine for patients with locally advanced gastric adenocarcinoma: long-term results of a phase III randomized controlled trial.Int J SurgPMID 37678277PMC107208372023-Dec-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Comparison of 18F-PSMA-1007 and 18F-Choline PET/CT in prostate cancer patients with biochemical recurrence: a phase 3, prospective, multicenter, randomized study.Nucl Med CommunPMID 37779440无 PMCID2023-Dec-010.95The study is a randomized, phase 3 trial in oncology with original results. However, it compares two diagnostic imaging agents (radiotracers) and evaluates diagnostic performance (detection rate, sensitivity), not a therapeutic drug intervention. Furthermore, it does not report a primary or key secondary time-to-event efficacy endpoint (OS, PFS, DFS, EFS, RFS, TTP, Kaplan-Meier, or HR).待处理
Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Phase 3 Randomized Clinical Trial.JAMA OncolPMID 37796513PMC105570312023-Dec-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Combination of aspirin and rosuvastatin for reduction of venous thromboembolism in severely injured patients: a double-blind, placebo-controlled, pragmatic randomized phase II clinical trial (The STAT Trial).Blood Coagul FibrinolysisPMID 37942744PMC106558422023-Dec-010.98未发现恶性肿瘤人群证据。待处理
Efficacy and Safety of Brolucizumab for Diabetic Macular Edema: The KINGFISHER Randomized Clinical Trial.JAMA OphthalmolPMID 37971723PMC125121742023-Dec-010.98未发现恶性肿瘤人群证据。待处理
Clinically meaningful improvements in cutaneous lesions and quality of life measures in patients with atopic dermatitis with greater pruritus reductions after treatment with 60 mg nemolizumab subcutaneously every 4 weeks: subgroup analysis from a phase 3, randomized, controlled trial.J Dermatolog TreatPMID 36779675无 PMCID2023-Dec0.98未发现恶性肿瘤人群证据。待处理